IndiaTickerGodavari Drugs Ltd - 530317 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Godavari Drugs
BSE:GODAVARI · ISIN INE362C01012
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Godavari Drugs
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Godavari Drugs Ltd - 530317 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Statement Of Deviation Or Variation In Utilisation Of Funds Raised Through Preferential Issue For The Quarter Ended March 31, 2026BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Financial Results For Period Ended 31St March,2026BSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday 27Th Day Of May,2026BSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Intimation for Board Meeting Intimation For The Fourth Quarter And Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Clarification On Price MovementBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Outcome Of Board Meeting Held On 18Th March, 2026.BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - Shareholder Meeting / Postal Ballot-Outcome of EGMBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Unaudited Financial Results Of The Company For The Quarter Ended December 31, 2025BSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Outcome Of Board Meeting And Disclosures Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.BSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ending On December 31, 2025.BSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - CORRIGENDUM IN CONTINUATION TO THE NOTICE AND EXPLANATORY STATEMENT ATTACHED THERETO DATED 15.01.2026 CONVENING THE 01St EXTRA ORDINARY GENERAL MEETING FOR FY 2025-26 OF GODAVARI DRUGS LIMITED TO BE HELD ON THURSDAY, 12.02.2026 AT 11:00 A.M.BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - EXTRA-ORDINARY GENERAL MEETING WILL BE HELD ON THURSDAY THE 12TH DAY OF FEBRUARY, 2026 AT 11:00 A.M. THROUGH VIDEO CONFERENCING AND OTHER AUDIO-VISUAL MEANSBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Preferential IssueBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Meeting Held On 15.01.2026BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Intimation for Options Of Consideration Of Fund-Raising ProposalBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Clarification On Price Movement In The Equity Shares Of Godavari Drugs Limited Ref: L/SURV/ONL/PV/AJ/ 2025-2026 / 3277BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Godavari Drugs Ltd - 530317 - Board Meeting Outcome for Unaudited Financial Statement For The Half-Year Ended 30Th September 2025BSE · exchange filing · pdf
Source filing Godavari Drugs Ltd - 530317 - Unaudited Financials Results Pursuant To Regulation 33 Of The SEBI(LODR) Regulations, 2015 For The Quarter And Half Year Ended 30Th September 2025BSE · financial results · pdf
Source filing